Literature DB >> 1403010

Hypertrophy and reversal of hypertrophy in rat pelvic ganglion neurons.

G Gabella1, T Berggren, B Uvelius.   

Abstract

An experimental procedure which chronically reduces the lumen of the urethra in adult female rats produced distension of the bladder and conspicuous thickening of its wall, resulting within 6-8 weeks in a ten-fold increase in muscle weight (muscle hypertrophy). During this process, the neurons in the pelvic ganglion that innervate the bladder undergo a large increase in size (neuronal hypertrophy). The average neuronal volume increased by 83%; small neurons became less numerous and large neurons became more numerous than in controls, but there was no increase in the maximum neuronal size. Six weeks after re-operation and removal of the urethral obstruction, the weight of the bladder was reduced (although not quite to the control levels), while the average neuronal size reversed to values very close to controls. In separate experiments, the pelvic ganglion of one side was removed. The nerve fibres in the hemidenervated bladder sprouted, grew and spread to innervate the whole bladder. The neurons in the surviving pelvic ganglion hypertrophied, the average cell volume increasing by 50% in seven weeks. The experiments showed that: (i) the pelvic neurons of adult rats are capable of very extensive growth when the tissue they innervate (bladder muscle) undergoes hypertrophy; (ii) the neuronal hypertrophy is reversible. This was taken to imply that there are factors within the bladder, including trophic substances, that regulate nerve cell volume not only by inducing growth but also by inducing the opposite effect, a cell size reduction; (iii) unilateral ganglionectomy, which did not induce muscle hypertrophy but doubled the amount of muscle innervated by the contralateral ganglion, was followed by marked neuronal hypertrophy.

Entities:  

Mesh:

Year:  1992        PMID: 1403010     DOI: 10.1007/bf01191726

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  9 in total

1.  In oculo transplants of myometrium from postpartum guinea pigs fail to support sympathetic reinnervation.

Authors:  M M Brauer; G Burnstock; C Thrasivoulou; T Cowen
Journal:  J Anat       Date:  1998-11       Impact factor: 2.610

2.  Specific targeting of ganglion cell sprouts provides an additional mechanism for restoring peripheral motor circuits in pelvic ganglia after spinal nerve damage.

Authors:  M E Kepper; J R Keast
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

Review 3.  Mitochondrial involvement in bladder function and dysfunction.

Authors:  C A Nevel-McGarvey; R M Levin; N Haugaard; X Wu; A P Hudson
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 4.  Neural control of the lower urinary tract: peripheral and spinal mechanisms.

Authors:  L Birder; W de Groat; I Mills; J Morrison; K Thor; M Drake
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  Pathophysiology of overactive bladder and urge urinary incontinence.

Authors:  William D Steers
Journal:  Rev Urol       Date:  2002

6.  Reversal of muscle hypertrophy in the rat urinary bladder after removal of urethral obstruction.

Authors:  G Gabella; B Uvelius
Journal:  Cell Tissue Res       Date:  1994-08       Impact factor: 5.249

7.  Lactate dehydrogenase activity and isoform distribution in the rat pelvic ganglion: effects of diabetes and bladder outlet obstruction.

Authors:  T Berggren; A Arner; B Uvelius
Journal:  Urol Res       Date:  1995

8.  The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO).

Authors:  Bárbara Frias; João Santos; Marlene Morgado; Mónica Mendes Sousa; Susannah M Y Gray; Karen D McCloskey; Shelley Allen; Francisco Cruz; Célia Duarte Cruz
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

9.  Neurotrophins in the lower urinary tract: becoming of age.

Authors:  Bárbara Frias; Tiago Lopes; Rui Pinto; Francisco Cruz; Célia Duarte Cruz
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.